Advance Search
LI Xia, YAO Tao, WANG Ying. Effect of semaglutide combined with metformin on ratio of serum apolipoprotein B to apolipoprotein A1, omentin-1 and fibroblast growth factor-21 in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 83-87. DOI: 10.7619/jcmp.20241699
Citation: LI Xia, YAO Tao, WANG Ying. Effect of semaglutide combined with metformin on ratio of serum apolipoprotein B to apolipoprotein A1, omentin-1 and fibroblast growth factor-21 in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 83-87. DOI: 10.7619/jcmp.20241699
shu

Effect of semaglutide combined with metformin on ratio of serum apolipoprotein B to apolipoprotein A1, omentin-1 and fibroblast growth factor-21 in patients with type 2 diabetes mellitus

  • Department of Endocrinology, Tangshan Nanhu Hospital, Tangshan, Hebei, 063000

More Information
  • Received Date: April 23, 2024
  • Revised Date: June 26, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the effect of semaglutide combined with metformin on the ratio of apolipoprotein B to apolipoprotein A1 (ApoB/ApoA1), omentin-1and fibroblast growth factor-21 (FGF-21) levels in patients with type 2 diabetes mellitus (T2DM).

    Methods 

    A total of 86 patients with T2DM were selected as research objects and randomly divided into control group (treated with metformin) and observation group (treated with semaglutide and metformin). The fasting blood glucose, 2-hour postprandial blood glucose, glycated hemoglobin, blood lipid indicators, insulin autoantibody (IAA), insulin resistance index (HOMA-IR), pancreatic β-cell function index (HOMA-β), ApoB/ApoA1, omentin-1, and FGF-21 levels before and after treatment were compared between the two groups. The occurrence of adverse reactions in both groups was also compared.

    Results 

    After treatment, the fasting blood glucose, 2-hour postprandial blood glucose, and glycated hemoglobin levels in the observation group were significantly lower than those in the control group (P < 0.05). After treatment, the total cholesterol, triglycerides, and low-density lipoprotein cholesterol levels in the observation group were significantly lower than those in the control group, while the high-density lipoprotein cholesterol level was significantly higher than that in the control group (P < 0.05). After treatment, the HOMA-IR and IAA in the observation group were significantly lower than those in the control group, while the HOMA-β was significantly higher than that in the control group (P < 0.05). After treatment, the serum omentin-1 level in the observation group was significantly higher than that in the control group, while the ApoB/ApoA1 and FGF-21 levels were significantly lower than those in the control group (P < 0.05). In the control group, there were 1 case of diarrhea and 2 cases of constipation, with a total incidence of adverse reactions of 6.98%; in the observation group, there were 1 case of hypoglycemia and 1 case of diarrhea, with a total incidence of adverse reactions of 4.65%; there was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).

    Conclusion 

    Semaglutide combined with metformin can effectively control blood glucose and blood lipid levels in patients with T2DM, increase omentin-1 level, and reduce ApoB/ApoA1 and FGF-21 levels.

    • FullText(HTML)
    • References (31)
  • [1]
    AKAGUN T, YELKEN B, USTA M, et al. Outcome of renal transplantation in patients with diabetes mellitus: a single-center experience[J]. Transplant Proc, 2022, 54(8): 2174-2178.
    [2]
    HANIFF H S, LIU X H, TONG Y Q, et al. A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype[J]. Cell Chem Biol, 2022, 29(2): 300-311, e10.
    [3]
    平丽贤. 胰岛素强化方法治疗老年成人隐匿性自身免疫性糖尿病患者的疗效及其对胰岛β细胞功能的影响[J]. 中国药物经济学, 2018, 13(9): 71-73.
    [4]
    蔡秀蕙, 丘世华, 陈丽玉. 2型糖尿病患者残余胆固醇与代谢相关脂肪性肝病相关性的研究[J]. 中国糖尿病杂志, 2023, 31(1): 31-36.
    [5]
    金晨, 刘慧慧, 孙颖, 等. 利拉鲁肽和艾塞那肽对2型糖尿病患者血糖及胃肠道反应的影响[J]. 中南医学科学杂志, 2023, 9(2): 269-272.
    [6]
    鞠阳, 江冉冉, 庞坤, 等. 二甲双胍对2型糖尿病患者桡骨远端骨折愈合的影响[J]. 实用药物与临床, 2023, 26(9): 791-795.
    [7]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华糖尿病杂志, 2014, 6(7): 447-498. doi: 10.3760/cma.j.issn.1674-5809.2014.07.004
    [8]
    KANEKO A, KANEMARU H, MIZUHASHI S, et al. Relationship between Type 2 diabetes mellitus and aggressiveness of melanoma[J]. J Dermatol Sci, 2022, 106(1): 65-67.
    [9]
    郝凯利, 王天吉, 马田成, 等. 二甲双胍对2型糖尿病患者脊柱内固定手术后远期功能的影响: 一项回顾性研究[J]. 空军军医大学学报, 2024, 45(4): 440-445, 449.
    [10]
    王花, 李光来, 罗蓉. 2型糖尿病患者脂联素、胱抑素C、载脂蛋白A1/载脂蛋白B与下肢动脉粥样硬化性疾病的关系[J]. 中国临床医生杂志, 2024, 52(1): 65-68.
    [11]
    印小蓉, 胡秀娟, 王淑倩, 等. 血糖变异系数与2型糖尿病周围神经病变的相关性分析[J]. 实用临床医药杂志, 2023, 27(13): 48-52. doi: 10.7619/jcmp.20231487
    [12]
    张磊, 乔岗, 韩丽, 等. 2型糖尿病患者炎性因子与糖脂代谢指标的相关性及其预测微血管病变的价值[J]. 实用临床医药杂志, 2023, 27(13): 114-118. doi: 10.7619/jcmp.20230092
    [13]
    ROTH M, LEHMANN T, KLOOS C, et al. Metabolic control, diabetic complications and drug therapy in a cohort of patients with type 1 and type 2 diabetes in secondary and tertiary care between 2004 and 2019[J]. Int J Environ Res Public Health, 2023, 20(3): 2631.
    [14]
    董丽娜, 牛姝, 王虹, 等. 利拉鲁肽联合二甲双胍对超重或肥胖2型糖尿病患者糖脂代谢及相关因子的影响[J]. 川北医学院学报, 2021, 7(12): 1604-1608.
    [15]
    LIM S, SOHN M, SHIN Y, et al. Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effects[J]. Diabetes Obes Metab, 2022, 24(4): 757-762.
    [16]
    孙峥, 王笑烨, 袁景, 等. 达格列净联合利拉鲁肽治疗非酒精性脂肪性肝病合并2型糖尿病患者短期疗效研究[J]. 实用肝脏病杂志, 2022, 8(6): 796-799.
    [17]
    徐爽, 童慧昕, 梁琳琅, 等. 二甲双胍、达格列净、利拉鲁肽联合治疗新诊断超重或肥胖2型糖尿病患者临床疗效及安全性[J]. 临床军医杂志, 2022, 50(12): 1252-1254, 1257.
    [18]
    王芳. FPG、2 h PG指导下胰岛素皮下注射治疗高龄妊娠期糖尿病患者的效果及对妊娠结局的影响[J]. 中外医学研究, 2019, 17(16): 107-109.
    [19]
    崔国英. 瑞舒伐他汀联合瑞格列奈对老年2型糖尿病治疗效果观察[J]. 中国现代药物应用, 2021, 15(19): 159-161.
    [20]
    RIZZA S, PIETRUCCI D, LONGO S, et al. Impact of insulin degludec/liraglutide fixed combination on the gut microbiomes of elderly patients with type 2 diabetes: results from A subanalysis of A small non-randomised single arm study[J]. Aging Dis, 2023, 14(2): 319-324.
    [21]
    BLONDE L, BELOUSOVA L, FAINBERG U, et al. Liraglutide as add-on to sodium-glucose co-transporter-2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial[J]. Diabetes Obes Metab, 2020, 22(6): 929-937.
    [22]
    陈晓涵, 郭雨淋, 仲小莉, 等. 司美格鲁肽联合卡格列净对肥胖型2型糖尿病患者血糖波动、BMI及胰岛功能的影响[J]. 牡丹江医学院学报, 2023, 44(5): 27-30, 16.
    [23]
    代闪, 王辰. 达格列净联合司美格鲁肽对2型糖尿病合并代谢相关脂肪性肝病患者糖脂代谢、肝功能和肝纤维化指标的影响[J]. 糖尿病新世界, 2023, 26(18): 25-29.
    [24]
    吴小颖, 陈彤华, 邢雪凤, 等. HbA1c、E2、C肽对围绝经期、绝经后2型糖尿病患者合并亚临床甲状腺功能减退症的诊断价值[J]. 中国现代医学杂志, 2023, 9(1): 24-31.
    [25]
    李潇萌, 吴少玉, 王媛媛. 非酒精性脂肪性肝病合并2型糖尿病患者血清同型半胱氨酸、成纤维细胞生长因子21和核因子-κB水平变化及其临床意义探讨[J]. 实用肝脏病杂志, 2023, 9(2): 202-205.
    [26]
    闫坤, 原丽敏, 张培育, 等. PPARα激动剂联合GLP-1 RAs对2型糖尿病患者Omentin-1、Asprosin水平的影响[J]. 广东医学, 2022, 8(1): 90-93.
    [27]
    王树华, 胡欢乐, 齐志娟, 等. 2型糖尿病足患者ApoB/ApoA1及其炎症指标检测结果分析[J]. 海南医学, 2021, 32(3): 301-304.
    [28]
    袁洁. apoB/apoA1与代谢综合征及胰岛素抵抗的关系[J]. 中国地方病防治, 2017, 3(6): 689-689, 691.
    [29]
    毋飞飞, 汪凌霄. 司美格鲁肽联合二甲双胍治疗超重或肥胖2型糖尿病的临床观察[J]. 中国卫生检验杂志, 2023, 33(17): 2122-2125.
    [30]
    黄文森, 邓少雄, 吴晴翼, 等. ApoB/ApoA1比值及non-HDL-C与2型糖尿病合并非酒精性脂肪肝病的相关性[J]. 山西医科大学学报, 2017, 48(8): 778-782.
    [31]
    范文, 郑元娟, 王维, 等. 司美格鲁肽注射液联合二甲双胍治疗老年2型糖尿病的疗效及对血清网膜素-1、Hcy和炎性因子的影响[J]. 中国老年学杂志, 2023, 9(18): 4378-4381.
    • Related Articles

  • Related Articles

    [1]LI Jia, WANG Lin, LIU Nan, WANG Ting, ZHAO Xiaoya, GAO Lini, ZHAO Ping. Effect of mindfulness training on sleep quality and psychological state of perimenopausal patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 85-88. DOI: 10.7619/jcmp.20222790
    [2]LIN Yan, ZHOU Ping, LI Yanzhen, LI Shiting. Effect of preoperative anxiety and depression and sleep qualityon sequelae of Bell's palsy and its intervention strategy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 30-33. DOI: 10.7619/jcmp.20201495
    [3]XI Lijuan, WANG Daorong, FANG Fang, YUAN Haijuan. Mediating effect of depression on sleep and preoperative frailty in elderly patients with gastrointestinal cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 50-54. DOI: 10.7619/jcmp.20201747
    [4]ZHANG Zhanhua, TIAN Feng. Expression of serum cortisol levels in post-stroke depression patients before and after treatment and its correlation with depression[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 34-36. DOI: 10.7619/jcmp.201924011
    [5]MEI Jing, WANG Chungang, BO Lin. Effect of SSRI anti depression drugs combined with conventional drugs for cerebral vascular disease on treatment of patients with post stroke depression[J]. Journal of Clinical Medicine in Practice, 2017, (1): 25-27. DOI: 10.7619/jcmp.201701007
    [6]CHEN Rende. The effect of duloxetine on sleeping quality of elderly female patients with depression[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 159-160.
    [7]JIA Jing, QIANG Xiaoling. Influence of comprehensive nursing interventions on depressive emotion and QOL in patients with depression[J]. Journal of Clinical Medicine in Practice, 2015, (16): 14-16. DOI: 10.7619/jcmp.201516005
    [8]QIU Yanli. The influence of psychological nursing intervention combined with massage on postpartum depression of patients[J]. Journal of Clinical Medicine in Practice, 2015, (2): 77-79,83. DOI: 10.7619/jcmp.201502024
    [9]Study on the relationship between quality of life and self-efficacy of patients with depressive disorder[J]. Journal of Clinical Medicine in Practice, 2014, (20): 15-18. DOI: 10.7619/jcmp.201420005
    [10]SONG Wenying. Influence of nursing intervention on the quality of life of patients with depression[J]. Journal of Clinical Medicine in Practice, 2013, (16): 147-149. DOI: 10.7619/jcmp.201316057

  • Cited by

    Periodical cited type(8)

    1. 陈春经，林焕明. 不同手术方式对剖宫产后子宫瘢痕憩室患者月经改善及妊娠结局的影响. 吉林医学. 2024(09): 2066-2069 .
    2. 黄玲，熊员焕，杨丽，许喜闻，姚冬爱，王萍. 经阴道病损切除术对剖宫产术后子宫瘢痕憩室的效果分析. 中国医药科学. 2023(06): 81-84+134 .
    3. 罗宁娜，郭水华，蔡云霞. 多功能阴式手术器械台在阴式手术患者中的应用效果. 医疗装备. 2022(15): 142-144 .
    4. 张红英，李新国. 腹腔镜手术、经阴道手术及宫腹腔镜联合手术三种方式治疗剖宫产瘢痕憩室的临床分析. 右江医学. 2021(11): 853-856 .
    5. 李玉霞，何运姣. 宫腹腔镜联合下手术治疗子宫切口憩室效果观察. 社区医学杂志. 2021(22): 1358-1361 .
    6. 储莉鸣，张治萍. 两种术式治疗子宫下段剖宫产切口瘢痕憩室的临床效果. 临床医学研究与实践. 2020(02): 105-106 .
    7. 刘付小清，赖火娣. 宫腔镜联合腹腔镜手术治疗剖宫产瘢痕憩室患者的价值分析. 齐齐哈尔医学院学报. 2020(13): 1612-1614 .
    8. 林玲，张丽丹. 宫腹腔镜联合用于剖宫产术后子宫瘢痕憩室的临床体会. 浙江创伤外科. 2020(06): 1178-1179 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (163) PDF downloads (5) Cited by(9)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return